Azelis and Tagra Receive Ringier Technology Innovation Award for CelluCap Resveratrol

Azelis, a leading speciality chemicals and food ingredients distributor, is very proud to announce it has won the 2019 Ringier Technology Innovation Award for Personal Care.

Competing with 80 companies and 140 ingredients, Azelis received the award for personal care, based on their research and work on Cellucap™ Resveratrol by Tagra Biotechnologies Ltd (Tagra).

Highlights & rationale

  • The Ringier Technology Innovation Awards are co-issued by Ringier Trade Media and Happi China Magazine and encourage the promotion of innovative and efficient ingredients.
  • The award criteria involves an extensive assessment and technical research and analysis on the ingredient's safety, efficacy, cost-effectiveness and sustainable character.
  • The selected material, Tagra's CelluCap™ Resveratrol, is encapsulated resveratrol, which facilitates production and prolonged effectiveness of the encapsulated active.
  • This is the eleventh innovation award for Azelis China in five consecutive years, which further demonstrates Azelis' continuous dedication to provide innovative services.

In CelluCap™ Resveratrol, the active resveratrol is encapsulated by a cellulose-based polymer, protecting the active from recrystallisation and discolouration by thermal and UV stimulation. As a powder form, CelluCap™ Resveratrol is easy to incorporate into the formulation at the final stage of filling, with no need for of solvents to dissolve the resveratrol. The microcapsules were designed using Release on Demand™ (RND™) technology, in order to release the active upon application, i.e. whilst applying the product onto the skin. As not all active is released immediately, some portion of the actives are brought onto the skin over time.

Jackson Chu, Managing Director Azelis China, comments: "We are very proud of the creative approach our technical team has chosen here. It confirms Azelis is not just a distributor, but a true innovative partner, who is dedicated to bring expertise and new, exclusive ingredients to the personal care market globally. This award reconfirms the quality and innovation that Azelis brings, based on the cutting-edge technology of our partner, Tagra."

Laurent Nataf, CEO & President Asia Pacific at Azelis, confirms: "This award is indeed yet another accolade for Azelis' dedication to the Asia Pacific region, and its expertise in the personal care field. We are very proud to receive this award, which serves as yet another testimony that we are dedicated to bring the best innovation services to this vastly growing market, together with our partners."

With 15 personal care application labs across the world, Azelis' focus and dedication clearly lie in being an innovative partner to all customers and principals. This vision of creating innovation through formulation has brought Azelis great recognition of the market, and the Chinese Personal Care team no less than eleven innovation awards in the past five years, this Ringier Technology Innovation Award being the most recent one.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Azelis. (2019, July 04). Azelis and Tagra Receive Ringier Technology Innovation Award for CelluCap Resveratrol. AZoM. Retrieved on November 21, 2024 from https://www.azom.com/news.aspx?newsID=51607.

  • MLA

    Azelis. "Azelis and Tagra Receive Ringier Technology Innovation Award for CelluCap Resveratrol". AZoM. 21 November 2024. <https://www.azom.com/news.aspx?newsID=51607>.

  • Chicago

    Azelis. "Azelis and Tagra Receive Ringier Technology Innovation Award for CelluCap Resveratrol". AZoM. https://www.azom.com/news.aspx?newsID=51607. (accessed November 21, 2024).

  • Harvard

    Azelis. 2019. Azelis and Tagra Receive Ringier Technology Innovation Award for CelluCap Resveratrol. AZoM, viewed 21 November 2024, https://www.azom.com/news.aspx?newsID=51607.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.